Valuation: Jamjoom Pharmaceuticals Factory Company

Market Cap 9.82B 2.62B 2.26B 2.13B 1.93B 3.63B 251B 3.69B 24.93B 9.77B 125B 9.61B 418B P/E 2026 *
18.7x
P/E 2027 * -
Enterprise Value 9.5B 2.53B 2.19B 2.06B 1.87B 3.52B 243B 3.57B 24.13B 9.46B 121B 9.3B 404B EV / Sales 2026 *
5.88x
EV / Sales 2027 * 5.03x
Free-Float
38.61%
Yield 2026 *
3.21%
Yield 2027 * 3.57%

Last Transcript: Jamjoom Pharmaceuticals Factory Company

1 day-0.36%
1 week-1.34%
Current month+1.90%
1 month-5.11%
3 months-10.41%
6 months+5.29%
Current year-2.04%
1 week 138.8
Extreme 138.8
143.3
1 month 134.5
Extreme 134.5
148.5
Current year 125
Extreme 125
163.7
1 year 125
Extreme 125
165.3
3 years 100.2
Extreme 100.2
202.4
5 years 66
Extreme 66
202.4
10 years 66
Extreme 66
202.4
Manager TitleAgeSince
Chief Executive Officer 62 2021-05-14
Director of Finance/CFO 62 2013-01-12
Chief Operating Officer 31 2021-08-31
Director TitleAgeSince
Director/Board Member - 2022-06-18
Chairman 66 2022-06-18
Director/Board Member 41 2022-06-18
Change 5-day change 1-year change 3-year change Capi.($)
-0.36%-1.34%-14.06%+23.14% 2.61B
-0.37%-3.56%+14.24%+63.79% 47.23B
+0.21%-4.14%+52.60%+119.23% 39.62B
-0.03%-2.49%-8.50%+15.32% 12.09B
-1.41%-0.30%+12.82%+73.00% 11.8B
+0.58%0.00%+30.65%+148.80% 9.12B
-0.54%-0.84%+22.33%+40.09% 7.57B
+1.33%+0.89%+42.84%-12.50% 7.1B
-1.03%+2.39%+12.74%+195.78% 6.87B
-0.97%-3.50%-30.77%+22.72% 5.81B
Average -0.26%-0.67%+13.49%+68.94% 14.98B
Weighted average by Cap. -0.19%-2.12%+22.89%+79.38%

Financials

2026 *2027 *
Net sales 1.62B 431M 372M 350M 318M 598M 41.27B 607M 4.11B 1.61B 20.64B 1.58B 68.74B 1.87B 498M 430M 405M 368M 692M 47.75B 702M 4.75B 1.86B 23.88B 1.83B 79.54B
Net income 521M 139M 120M 113M 102M 193M 13.3B 196M 1.32B 518M 6.65B 510M 22.15B -
Net Debt -317M -84.43M -72.92M -68.61M -62.36M -117M -8.09B -119M -805M -315M -4.05B -310M -13.48B -404M -108M -92.94M -87.44M -79.47M -149M -10.31B -152M -1.03B -402M -5.16B -395M -17.18B
Logo Jamjoom Pharmaceuticals Factory Company
Jamjoom Pharmaceuticals Factory Company SJSC is a Saudi Arabia-based pharmaceutical company, which is primarily focused on developing, manufacturing, and distributing generic pharmaceuticals, cosmetics, and consumer healthcare products. It produces human medicines, nutraceuticals, antibiotics, general analgesics, medicines for treatment of cough, allergy, asthma, heart diseases, blood pressure, diarrhoea, vomiting, and ulcer and acidity, among others. It operates in two segments: The Pharmaceutical products that represents medicines or drugs for the prevention and treatment of diseases, and protection of public health; and The Consumer health products that represents products used to support personal well-being, maintain health, or address specific health-related needs. The Company’s subsidiaries include Al Jamjoom Pharma for Pharmaceutical Industries and Jamjoom Pharmaceutical Industry and Commerce Company Limited and the Company also operates approximately 8 branches.
Employees
-
Date Price Change Volume
26-08-18 SAR 139.40 -0.36% 36,456
26-08-17 SAR 139.90 -1.13% 26,506
26-08-16 SAR 141.50 -0.35% 35,610
26-08-13 SAR 142.00 +0.28% 14,043
26-08-12 SAR 141.60 +0.78% 59,646
Trader
Investor
Global
Quality
ESG MSCI
B
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
3
Last Close Price
139.40SAR
Average target price
164.24SAR
Spread / Average Target
+17.82%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 4015 Stock